v3.24.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Cash flows from operating activities:    
Net loss $ (940,935) $ (1,412,070)
Adjustments to reconcile net loss to net cash used in operating activities:    
Amortization of debt discount 37,112
Stock-based compensation 336,293
Common stock issued for settlement of payables 239,815
Common stock issued for legal settlements 74,053
Credit loss expense 25,500 64,000
Changes in operating assets and liabilities:    
Accounts receivable (267,603) (50,650)
Prepaid expenses and other assets (5,850) 10,147
Accounts payable and accrued liabilities 107,298 538,998
Deferred revenue (219,250) (188,000)
Net cash used in operating activities (949,860) (701,282)
Net cash from investing activities:
Cash flows from financing activities:    
Proceeds from the sale of common stock 572,906
Proceeds from loans payable 994,500
Payments on loans payable (48,410) (47,847)
Payments of shareholder advance (24,283)
Proceeds from accounts payable and accrued liabilities - related party 128,479 183,558
Payments on accounts payable and accrued liabilities - related party (128,479) (160,085)
Net cash provided by financing activities 946,090 524,249
Net decrease increase in cash (3,770) (177,033)
Cash, beginning of period 91,436 249,462
Cash, end of period 87,666 72,429
Supplemental disclosures of cash flow information:    
Cash paid for interest 30,499 5,932
Cash paid for income taxes
Non-cash investing and financing activities:    
Shares issued for vested restricted stock units 2 16
Shares issued for settlement of class action 600,000
Shares issued for cashless exercise of warrants 15
Shares issued for accrued legal settlement 285,294
Beneficial conversion feature on convertible loans $ 973,200

Source

PDF HTML
10-Q Filing
ZIP XLS HTML
XBRL